Priti Hegde, PhD, Chief Scientific Officer
Dr. Hegde joined Foundation Medicine as the Chief Scientific Officer in August 2019. Her team comprises of Cancer Genomics, Research and Early Development, Computational Biology, Translational Strategy, Franchise Development, and Product Development (inclusive of Assay Development, Companion Diagnostic Development Operations, Regulatory, and Biomarkers and Biometrics).
Dr. Hegde has spent nearly two decades in the biopharmaceutical industry, with a proven track record in drug development, registration, and commercialization of therapeutics with companion diagnostics in cancer immunotherapy.
Current Open Roles on the Team:
| Scientist II, Computational Biology | Computational Biology | 102353 | San Diego | California | United States | Torreyana Road, San Diego, California, United States | R&D | About the Job The Scientist II, Computational Biology on the Computational Biology team collaborates with a multidisciplinary team of scientists by developing the computational analytics components of future products and enriching the analytical... | ||
| Sr Research Associate, Assay Development | Assay Development | 102304 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | R&D | About the Job The Senior Research Associate (SRA), Assay Development support late-stage development, design and laboratory systems integration of Next Generation Sequencing (NGS)-based molecular diagnostic assays for internal and external resear... | ||
| Sr Software Engineer | Computational Biology | 102290 | Boston | Massachusetts | United States | Seaport Blvd., Boston, Massachusetts, United States | R&D | About the Job This position is a member of the Pipeline Engineering sub-team of the Computational Biology, Engineering group. This team is responsible for developing components of, and programmatic interfaces to, the genomics platform and analys... | ||
| Assoc Dir, Regulatory Affairs | Regulatory | 102277 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | R&D | About the Job The Associate Director, Regulatory Affairs is responsible for supporting the regulatory function and its activities, the development of regulatory strategy, and contributing the regulatory approval process (including US FDA and oth... | ||
| Scientist II, Computational Biology | Computational Biology | 102252 | Boston | Massachusetts | United States | Seaport Blvd., Boston, Massachusetts, United States | R&D | About the Job The Scientist II, Computational Biology on the Computational Biology Team provides computational, bioinformatic and statistical activities to enrich the analytical capabilities of existing products as medical knowledge advances, as... | ||
| Sr Scientist, Computational Biology | Computational Biology | 102247 | Boston | Massachusetts | United States | Seaport Blvd., Boston, Massachusetts, United States | R&D | About the Job The Senior Scientist, Computational Biology on the Computational Biology team provides computational, bioinformatic, and statistical expertise and leadership to enrich the analytical capabilities of existing products, as well as to... | ||
| Biostatistician II | Biomarkers and Biometrics | 102228 | Boston | Massachusetts | United States | Seaport Blvd., Boston, Massachusetts, United States | R&D | About the Job The Biostatistician II is responsible for providing statistical expertise and managing the activities for personalized medicine companion diagnostic device analytical and clinical studies. This position ensures valid and efficient ... | ||
| Sr. Research Associate | Cancer Genomics | 102170 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | R&D | About the Job The Senior Research Associate manages and contributes to research, implementation, and validation of computational methods for FMI’s internal Cancer Genomics Research group. The position’s contributions focus on development of clin... | ||
| Computational Biologist II | Cancer Genomics | 101948 | Cambridge | Massachusetts | United States | Cambridge, Massachusetts, United States | R&D | About the Job The Computational Biologist II, Machine Learning contributes to research, implementation, and validation of computational methods for FMI’s Research and Cancer Genomics Research groups. The position’s contributions focus on feasibi... |
If you’re looking for a team at Foundation Medicine with a cross-functional reach, you need not look any further than the Regulatory Affairs team. Operating within our Research and Development (R&D) function, the team serves a critical role as a collaborative, results-driven partner, driving development and supporting the launch of transformational products, as well as influencing the global regulatory and policy environment in which they operate. They offer key insights, strategy, and support to bring our products to market, serving our patients, physicians, and research partners both in the U.S. and in ex-U.S. markets.
Learn more about Regulatory Affairs here.
When the Diagnostic Development and Validation (DD&V) Team at Foundation Medicine arrives for work each day, they are stepping into roles that epitomize the company’s value of collaboration. The team operates as a bridge between Product Development and Laboratory Operations through their focus on late-stage product development, validation, and transfer of knowledge. The team’s mission is to ensure that Foundation Medicine’s laboratory tests are safe and effective, enabling important diagnostic insights for partners and patients. Their collaboration with different partners across the company contributes to technical expertise within Foundation Medicine’s design and development process for new and existing products.
Learn more about DD&V here.
The Power Of Partnership In Precision Medicine
FoundationOne CDx was recently approved to identify mutations that lead to MET exon 14 skipping in advanced non-small cell lung cancer (NSCLC) and match patients with a new targeted therapy, which was approved in parallel.
Learn more on our blog about how this approval demonstrates the power of cancer precision medicine in action and the role that comprehensive genomic profiling plays.
- Garrett Frampton, PhD, Sr. Director, Cancer Genomics
The Best of the AACR Journals Collection
The Best of the AACR Journals collection highlights the most-cited articles published in 2018 across the AACR journals. Congratulations to our Director of Cancer Genomics Research, Lee A. Albacker for his most-cited article entitled STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.
Learn a bit more about us:
